Pathophysiology Ivan Damjanov Pdf 139 Page

If you clarify the actual subject of page 139 (e.g., by quoting a sentence or heading), I can rewrite the essay precisely. Introduction In Pathophysiology , Ivan Damjanov emphasizes that disease arises from disordered physiology rather than isolated structural abnormalities. A paradigmatic example is thrombosis—the pathologic formation of a blood clot (thrombus) within the vasculature—and its downstream consequence, embolism. These processes underlie myocardial infarction, ischemic stroke, and pulmonary embolism. Understanding their pathophysiology requires integrating Virchow’s triad (endothelial injury, stasis, hypercoagulability) with molecular insights into hemostatic regulation. This essay explores the mechanisms, clinical evolution, and systemic impact of thrombosis and embolism, drawing on standard content from Damjanov-level teaching. 1. Endothelial Injury: The Initiating Event The vascular endothelium is not a passive liner but a dynamic organ maintaining anticoagulant properties via heparan sulfate, thrombomodulin, and tissue factor pathway inhibitor. Endothelial injury—caused by atherosclerosis, trauma, hypertension, or toxins—exposes subendothelial collagen and tissue factor. This switch from anticoagulant to procoagulant surface triggers platelet adhesion (via von Willebrand factor) and activation. Damjanov highlights that even microscopic endothelial denudation can initiate thrombus formation, particularly in arteries where high shear forces prevail. 2. Hemodynamic Factors: Stasis and Turbulence Blood flow normally dilutes activated clotting factors and prevents platelet aggregation. Stasis (prolonged immobility, atrial fibrillation, ventricular aneurysm) allows thrombin accumulation and clot propagation. Turbulence (as in arterial bifurcations or stenotic valves) disrupts laminar flow, causing endothelial cell activation and expression of adhesion molecules. Venous thrombi (red thrombi) form in stasis, rich in fibrin and trapped erythrocytes; arterial thrombi (white thrombi) form under high shear, platelet-rich. Damjanov’s text typically contrasts these morphologies to illustrate how hemodynamics shape thrombus composition. 3. Hypercoagulability: Genetic and Acquired Drivers Hypercoagulability tilts the hemostatic balance toward thrombosis. Primary causes include Factor V Leiden mutation (resistance to activated protein C), prothrombin G20210A mutation, and antithrombin III deficiency. Acquired causes are more common: cancer (via tissue factor secretion and mucin production), antiphospholipid syndrome (autoantibodies against phospholipid-binding proteins), pregnancy, oral contraceptive use, and heparin-induced thrombocytopenia. Damjanov stresses that hypercoagulability rarely causes thrombosis alone but synergizes with stasis or endothelial injury. 4. From Thrombus to Embolus: The Dangerous Journey An embolus is any intravascular mass (thrombus, fat, air, amniotic fluid, tumor cells) that travels to a distant site. Thromboembolism—fragmentation or dislodgement of a thrombus—is the most clinically significant. Venous thrombi (typically from deep leg veins) travel to pulmonary arteries, causing pulmonary embolism (PE). Arterial thrombi (from left heart, aortic arch, or carotid arteries) embolize to brain, kidneys, or lower limbs. Paradoxical embolism occurs when a venous thrombus crosses an atrial or ventricular septal defect into systemic circulation.